{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T18:48:02Z","timestamp":1793126882258,"version":"4.5.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T00:00:00Z","timestamp":1586390400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T00:00:00Z","timestamp":1586390400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["K23DK118189"],"award-info":[{"award-number":["K23DK118189"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Idiopathic nephrotic syndrome has a relapsing-remitting course in the majority of pediatric patients, demanding vigilant monitoring and self-management. A novel, expert-designed, user-informed mobile application (app), UrApp\u00a9, was created to support management tasks, including home urine protein monitoring.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>The UrApp Pilot Study (<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/clinicaltrials.gov\">ClinicalTrials.gov<\/jats:ext-link>, <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04075656\">NCT04075656<\/jats:ext-link>) is a randomized trial comparing UrApp-supported nephrotic syndrome management with standard-of-care with parallel process evaluation of the intervention delivery. Sixty caregivers of children with newly diagnosed, steroid-sensitive nephrotic syndrome will be randomized 1:1 to UrApp-supported care or standard-of-care. Follow-up will be 1 year, with primary outcomes of adherence to urine monitoring and medications assessed at 6 and 12\u2009months. Secondary outcomes at 6 and 12\u2009months include self-efficacy, quality-of-life, hospitalizations and delayed relapse diagnoses. A mixed-methods approach will evaluate UrApp engagement, use retention, features used, user perceptions, and contextual barriers and facilitators of UrApp use. User behavior will be assessed for relationships to the primary and secondary outcomes. A Stakeholder Committee of volunteer trial participants, clinicians, and engineers will examine the trial results and design a pragmatic UrApp-enhanced nephrotic syndrome intervention with potential for wide implementation. The final UrApp intervention will be tested in a user-centered hybrid effectiveness-implementation trial designed with stakeholder input.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Discussion<\/jats:title>\n<jats:p>The UrApp Pilot Study examines the efficacy of a novel app designed specifically for nephrotic syndrome. The protocol involves dual efficacy and process evaluation aims to increase efficiency and incorporates the stakeholders\u2019 perspective in formative assessment to inform intervention redesign and the design of a future user-centered trial.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Trial registration<\/jats:title>\n<jats:p><jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/clinicaltrials.gov\">ClinicalTrials.gov<\/jats:ext-link>, <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04075656\">NCT04075656<\/jats:ext-link>. Registered on September 2, 2019, <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04075656\">https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04075656<\/jats:ext-link><\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12882-020-01778-w","type":"journal-article","created":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T12:03:27Z","timestamp":1586433807000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A dual efficacy-implementation trial of a novel mobile application for childhood nephrotic syndrome management: the UrApp for childhood nephrotic syndrome management pilot study protocol (UrApp pilot study)"],"prefix":"10.1186","volume":"21","author":[{"given":"Chia-shi","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cam","family":"Escoffery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel E.","family":"Patzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"McCracken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle N.","family":"Rheault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amira","family":"Al-Uzri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry A.","family":"Greenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,9]]},"reference":[{"issue":"9384","key":"1778_CR1","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(03)14184-0","volume":"362","author":"AA Eddy","year":"2003","unstructured":"Eddy AA, Symons JM. Nephrotic syndrome in childhood. Lancet. 2003;362(9384):629\u201339.","journal-title":"Lancet"},{"key":"1778_CR2","doi-asserted-by":"crossref","unstructured":"Primary nephrotic syndrome in children: clinical significance of histopathologic variants of minimal change and of diffuse mesangial hypercellularity. A Report of the International Study of Kidney Disease in Children. Kidney Int. 1981;20(6):765\u201371.","DOI":"10.1038\/ki.1981.209"},{"key":"1778_CR3","doi-asserted-by":"crossref","unstructured":"The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the International Study of Kidney Disease in Children. J Pediatr. 1981;98(4):561\u20134.","DOI":"10.1016\/S0022-3476(81)80760-3"},{"issue":"8","key":"1778_CR4","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nrneph.2012.115","volume":"8","author":"LA Greenbaum","year":"2012","unstructured":"Greenbaum LA, Benndorf R, Smoyer WE. Childhood nephrotic syndrome--current and future therapies. Nat Rev Nephrol. 2012;8(8):445\u201358.","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"1778_CR5","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s00467-012-2310-x","volume":"28","author":"RM Lombel","year":"2013","unstructured":"Lombel RM, Gipson DS, Hodson EM. Kidney disease: improving global O: treatment of steroid-sensitive nephrotic syndrome: new guidelines from KDIGO. Pediatr Nephrol. 2013;28(3):415\u201326.","journal-title":"Pediatr Nephrol"},{"key":"1778_CR6","doi-asserted-by":"publisher","first-page":"2029583","DOI":"10.1155\/2017\/2029583","volume":"2017","author":"CS Wang","year":"2017","unstructured":"Wang CS, Yan J, Palmer R, Bost J, Wolf MF, Greenbaum LA. Childhood Nephrotic syndrome management and outcome: a single center retrospective analysis. Int J Nephrol. 2017;2017:2029583.","journal-title":"Int J Nephrol"},{"issue":"6","key":"1778_CR7","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1053\/j.ajkd.2012.12.025","volume":"61","author":"DS Gipson","year":"2013","unstructured":"Gipson DS, Messer KL, Tran CL, Herreshoff EG, Samuel JP, Massengill SF, Song P, Selewski DT. Inpatient health care utilization in the United States among children, adolescents, and young adults with nephrotic syndrome. Am J Kidney Dis. 2013;61(6):910\u20137.","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"1778_CR8","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s00467-012-2310-x","volume":"28","author":"RM Lombel","year":"2013","unstructured":"Lombel RM, Gipson DS, Hodson EM. Kidney disease: improving global outcomes: treatment of steroid-sensitive nephrotic syndrome: new guidelines from KDIGO. Pediatr Nephrol. 2013;28(3):415\u201326.","journal-title":"Pediatr Nephrol"},{"key":"1778_CR9","unstructured":"Wang CTJ, Srivastava T, Weidemann D, Greenbaum LA. Medication adherence and perceived difficulties in pediatric nephrotic syndrome. In: ASN. 2017;2017."},{"issue":"suppl_1","key":"1778_CR10","doi-asserted-by":"publisher","first-page":"i98","DOI":"10.1093\/ndt\/gfw344","volume":"32","author":"H Beanlands","year":"2017","unstructured":"Beanlands H, Maione M, Poulton C, Herreshoff E, Hladunewich MA, Hailperin M, Modes MM, An L, Nunes JW, Trachtman H, et al. Learning to live with nephrotic syndrome: experiences of adult patients and parents of children with nephrotic syndrome. Nephrol Dial Transplant. 2017;32(suppl_1):i98\u2013i105.","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"1778_CR11","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12911-019-0822-z","volume":"19","author":"CS Wang","year":"2019","unstructured":"Wang CS, Boyd R, Mitchell R, Wright WD, McCracken C, Escoffery C, Patzer RE, Greenbaum LA. Development of a novel mobile application to detect urine protein for nephrotic syndrome disease monitoring. BMC Med Inform Decis Mak. 2019;19(1):105.","journal-title":"BMC Med Inform Decis Mak"},{"issue":"8","key":"1778_CR12","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.ekir.2019.04.026","volume":"4","author":"C-s Wang","year":"2019","unstructured":"Wang C-s, Troost JP, Greenbaum LA, Srivastava T, Reidy K, Gibson K, Trachtman H, Piette JD, Sethna CB, Meyers K, et al. Text messaging for disease monitoring in childhood Nephrotic syndrome. Kidney International Reports. 2019;4(8):1066\u201374.","journal-title":"Kidney International Reports"},{"key":"1778_CR13","doi-asserted-by":"crossref","unstructured":"Nephrotic syndrome in children: prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. A report of the International Study of Kidney Disease in Children. Kidney Int. 1978;13(2):159\u201365.","DOI":"10.1038\/ki.1978.23"},{"issue":"1","key":"1778_CR14","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/00005650-198601000-00007","volume":"24","author":"DE Morisky","year":"1986","unstructured":"Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67\u201374.","journal-title":"Med Care"},{"key":"1778_CR15","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1477-7525-11-30","volume":"11","author":"DS Gipson","year":"2013","unstructured":"Gipson DS, Selewski DT, Massengill SF, Wickman L, Messer KL, Herreshoff E, Bowers C, Ferris ME, Mahan JD, Greenbaum LA, et al. Gaining the PROMIS perspective from children with nephrotic syndrome: a Midwest pediatric nephrology consortium study. Health Qual Life Outcomes. 2013;11:30.","journal-title":"Health Qual Life Outcomes"},{"key":"1778_CR16","doi-asserted-by":"publisher","first-page":"h1258","DOI":"10.1136\/bmj.h1258","volume":"350","author":"GF Moore","year":"2015","unstructured":"Moore GF, Audrey S, Barker M, Bond L, Bonell C, Hardeman W, Moore L, O'Cathain A, Tinati T, Wight D, et al. Process evaluation of complex interventions: Medical Research Council guidance. BMJ. 2015;350:h1258.","journal-title":"BMJ"},{"issue":"2","key":"1778_CR17","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1177\/1524839904273387","volume":"6","author":"RP Saunders","year":"2005","unstructured":"Saunders RP, Evans MH, Joshi P. Developing a process-evaluation plan for assessing health promotion program implementation: a how-to guide. Health Promot Pract. 2005;6(2):134\u201347.","journal-title":"Health Promot Pract"},{"issue":"2","key":"1778_CR18","first-page":"3","volume":"8","author":"A Lund","year":"2001","unstructured":"Lund A. Measuring usability with the USE questionnaire. Usability Interface. 2001;8(2):3\u20136.","journal-title":"Usability Interface"},{"key":"1778_CR19","volume-title":"Qualitative research methods","author":"M Hennink","year":"2011","unstructured":"Hennink M, Hutter I, Bailey A. Qualitative research methods. London: Sage; 2011."},{"issue":"1","key":"1778_CR20","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s11136-017-1581-x","volume":"27","author":"L Forsythe","year":"2018","unstructured":"Forsythe L, Heckert A, Margolis MK, Schrandt S, Frank L. Methods and impact of engagement in research, from theory to practice and back again: early findings from the Patient-Centered Outcomes Research Institute. Qual Life Res. 2018;27(1):17\u201331.","journal-title":"Qual Life Res"},{"issue":"2","key":"1778_CR21","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1370\/afm.2042","volume":"15","author":"S Sheridan","year":"2017","unstructured":"Sheridan S, Schrandt S, Forsythe L, Hilliard TS, Paez KA. Advisory panel on patient E: the PCORI engagement rubric: promising practices for partnering in research. Ann Fam Med. 2017;15(2):165\u201370.","journal-title":"Ann Fam Med"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-020-01778-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12882-020-01778-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-020-01778-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T23:11:45Z","timestamp":1617923505000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-020-01778-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,9]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1778"],"URL":"https:\/\/doi.org\/10.1186\/s12882-020-01778-w","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,9]]},"assertion":[{"value":"12 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Institutional Review Boards of Emory University (lead site, Version 1, January 30, 2019), University of Minnesota, and Oregon Health and Science University. Caregiver consent and patient assent will be obtained per local institutional review board (IRB) guidelines.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"MNR receives research support from Advicenne, Genentech, Reata Pharmaceuticals, and Retrohin unrelated to the content of this manuscript. RP is an Associate Editor of <i>BMC Nephrology<\/i>.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"125"}}